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Identification of Antibiotic Producing Soil Bacteria Against 
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Morgan Brockhouse and Dr. Lori Scott
INTRODUCTION
Antibiotic resistant bacteria are becoming a serious threat to people
in the United States, especially in hospital settings. These infections
are called nosocomial infections because they are caught while in a
hospital and are potentially resistant to antibiotics (10). According to
the Centers for Disease Control and Prevention (CDC), at least 2.8
million people obtain an antibiotic-resistant infection in the U.S.
each year, and more than 35,000 people die from these infections
(3). The Infectious Diseases Society of America refers to these
nosocomial bacteria as ESKAPE pathogens, which is an acronym
that stands for Enterococcus faecium, Staphylococcus aureus,
Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas
aeruginosa, & Enterobacter species (10). When a bacteria is
resistant to an antibiotic, there are usually other antibiotics that can
be used as they target different areas of the cell. However, bacteria
are becoming multi-drug resistant creating a need for new
antibiotics to be discovered.
In order to study this antibiotic crisis, the Tiny Earth Project
Initiative (TEPI) is collecting data from students and instructors to
discover new antibiotics from soil (5). Soil contains an abundance of
diverse microbes that have evolved within their competitive
environment (4). Some bacteria have adapted to produce secondary
metabolites, which are organic compounds released in order to
enhance the bacteria’s chance of survival. An antibiotic is a type of
secondary metabolite that inhibits the growth of surrounding
microorganisms. Therefore, it is possible to discover new antibiotics
from soil bacteria.
The current research tests for antibiotics produced against the
ESKAPE-like microbes Bacillus subtilis and Escherichia coli.
Fig. 1. Isolated colonies developed on streak plates of LB agar with
E. coli (left) and B. subtilis (right). E. coli colonies appear beige,
moist, circular with entire margins, and flat in elevation. B. subtilis
colonies appear cream, matte, irregular shaped with undulate
margins, and flat in elevation. These plates were incubated at 28oC
for 24 hours.
B. subtilis is a common, fast-growing decomposer found in soil (7).
Its cells are rod-shaped, gram-positive, and often arranged in short
chains. The resistance of its spores to heat, radiation, and
disinfectants results in the bacteria being difficult to completely
remove from unwanted locations. E. coli is a gram-negative, rod-
shaped bacteria commonly found in a single cell arrangement (8). It
can beneficial to humans as it is an important species in the normal
intestinal microflora, but it has also shown to be pathogenic (6).
It is important to study these ESKAPE-like bacteria in order to
prevent increased antibiotic resistance and discover resolutions to
the antibiotic-resistance crisis. The purpose of this research is to
contribute to the TEPI by assessing ESKAPE-like pathogens to find
possible antibiotics produced from soil bacteria.
METHODS
Unless described otherwise, the bacterial strains and protocols used in
this study were provided by TEPI (5).
• Collected soil sample: damp soil in a forested area with fallen 
leaves; Temperature of air = 13oC
• Performed serial dilutions of soil sample on LB agar, 10% TSA, 
and PDA
• Created master plates of each media
• Used two techniques to isolate antibiotic production on B. subtilis
and E. coli
• Created streak plates of four isolates that seemed to produce 
antibiotic
• Used technique #2 to confirm antibiotic producers
• Performed colony PCR and agarose gel electrophoresis on four 
isolates; Used 16S rRNA primers 27F and 1492R
• Performed DNA extraction on isolates #25 and #29 using IBI 
extraction kit
• Prepared DNA sequencing sample and sent it to Iowa Institute of 
Human Genetics at Univ. of Iowa; Used 16S rRNA sequence to 
identify isolates using BLAST analysis (2)
• Performed Biochemical tests and Gram stains
DISCUSSION
Four antibiotic producing bacteria were isolated from a soil sample,
and two of these isolates were sequenced using the 16S rRNA gene.
The sequencing data revealed that the isolates are most related to the
genus Pseudomonas, which is a common type of soil bacteria (1).
Many species of Pseudomonas are known antibiotic producers,
further confirming these isolated samples as antibiotic producing
soil bacteria (9). Future research should test these isolates on
different tester strains to possibly identify the mode of action of the
antibiotic. The specific gene controlling the enzyme that produces
the antibiotic should also be identified and researched.
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RESULTS
Fig. 2. Confirmation of antibiotic producing isolates on LB and 10% TSA agar
against B. subtilis and E. coli. Plate A contains 3 streaks of isolates #25 (left) and
#29 (right) on B. subtilis and LB agar. All streaks on plate A produced clear halos
revealing antibiotic production. Plate B contains 3 streaks of isolate #29 on E. coli
and LB agar, which did not produce clear halos. Plate C contains 3 streaks of
isolates #15 (left) and #20 (right) on B. subtilis and 10% TSA. Streaks from isolate
#15 produced slight halos, and streaks from #20 produced irregular shaped halos.
Plates were incubated at 28oC for 24 hours.
Fig. 3. Agarose gel electrophoresis revealing isolated 16S rRNA from soil bacterial
isolates with evidence of producing antibiotics. Lane 1 = molecular weight marker;
Lane 3 = sample #25 grown on LB agar; Lane 5 = sample #29 grown on LB agar;
Lane 7 = sample #15 grown on TSA; Lane 9 = sample #20 grown on TSA. All
isolates previously showed evidence of producing antibiotic against B. subtilis. A
1% agarose gel was run at 100V for 25 minutes.
RESULTS (CONTINUED)
Fig. 4. Isolated colonies developed on streak plates of potential antibiotic
producers on LB (plates A and B) and 10% TSA agar (plates C and D). Sample
#25 has moist, cream, circular colonies with entire margins and a flat elevation.
Sample #29 has shiny, beige, circular colonies with entire margins and a convex
elevation. Sample #15 has matte, white, irregular colonies with undulate
margins and a flat elevation. Sample #20 has moist, orange, opaque, circular
colonies with entire margins and a flat elevation. Plates were incubated at 28oC
for 24 hours.
Fig. 5. 16S rRNA sequence data for isolates #25 (top) and #29 (bottom) are
most related to the genus Pseudomonas, as determined by BLAST analysis (2).
